eHealth, Inc. Q1 2010 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2010. eHealth, Inc. operates an Internet-based insurance agency platform enabling individuals, families, and small businesses to research, compare, and purchase health insurance products. The company is licensed in all 50 states and the District of Columbia. Revenue is primarily derived from commissions paid by health insurance carriers, with secondary revenue from sponsorship advertising and technology licensing.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Total Revenue | $35.99 million | $31.92 million |
| Net Income | $3.23 million | $3.14 million |
| Diluted EPS | $0.13 | $0.12 |
| Operating Cash Flow | $3.09 million | $4.72 million |
| Cash & Equivalents (End of Period) | $154.36 million | $94.32 million |
| Marketable Securities | $4.21 million | $22.18 million |
| Total Assets | $174.91 million | $169.71 million |
| Effective Tax Rate | 45.5% | 47.5% |
Debt and Liquidity: The company reported no bank debt or line of credit facilities. Total current liabilities decreased to $12.99 million from $15.26 million in the prior year. Liquidity remains strong with total cash, cash equivalents, and marketable securities totaling approximately $158.6 million as of March 31, 2010.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 13% year-over-year, driven by a 13% increase in commission revenue ($31.77 million) and a 14% increase in sponsorship/licensing revenue ($4.22 million). This growth correlates with an estimated 11% increase in total membership to 755,200.
- Expense Increases: Total operating costs rose 14% to $30.09 million. Notable increases include:
- Marketing & Advertising: Up 10% to $14.82 million, primarily due to higher paid keyword search advertising costs.
- Technology & Content: Up 28% to $4.58 million, driven by personnel increases and stock-based compensation.
- General & Administrative: Up 23% to $5.77 million, due to higher legal fees and stock-based compensation.
- Acquisition Cost: The cost of acquiring new members increased 17% to $73.68 per individual on submitted applications, up from $62.95 in Q1 2009.
- Interest Income: Interest and other income dropped 93% to $28,000, reflecting a decline in market interest rates on invested cash and securities.
- Application Trends: Submitted applications for individual and family health insurance declined 4% year-over-year, attributed to consumer confusion regarding healthcare reform, weak economic conditions, and the COBRA subsidy program.
Guidance, Outlook, and Risks
- Acquisition: On April 30, 2010, eHealth acquired PlanPrescriber, Inc. for approximately $28.7 million in cash. This acquisition aims to accelerate entry into the Medicare market. Results will be consolidated starting from the acquisition date.
- Outlook: Management expects total revenue to increase in 2010 compared to 2009. However, they anticipate marketing and advertising expenses will increase in absolute dollars and remain equal to or higher than 2009 levels as a percentage of revenue. The average cost of acquiring new members is expected to be higher in 2010.
- Risks:
- Healthcare Reform: The Patient Protection and Affordable Care Act (signed March 2010) introduces significant uncertainty regarding future commission structures, the role of agents, and consumer demand.
- Carrier Concentration: Three carriers (Aetna, UnitedHealthcare, Wellpoint) represented approximately 44% of total revenue in Q1 2010.
- Regulatory Compliance: The company faces complex regulations across 50 states and new federal requirements for Medicare products.
Investor Verification Checklist
- Verify the integration progress and financial impact of the PlanPrescriber acquisition.
- Monitor the trend of submitted applications versus approved members to assess the impact of healthcare reform and the COBRA subsidy expiration.
- Review the sustainability of the rising customer acquisition cost ($73.68) relative to the lifetime value of a member.
- Assess the company's exposure to the top three insurance carriers and the risk of commission rate reductions.
- Confirm the timeline for the rollout of Medicare product offerings and associated regulatory approvals.